Application no. and date | 01952420.6 (espacenet) (Federated) (European Patent Register), 20010702 | Patent/reg. no. and date | DK/EP 1372696, 20080723 | Publication date | 20040102 | Priority no. and date | US 215913 P, 20000703 | EP pub. no. and date |
EP 1372696 20040102 | Effective date | | Applicant/owner | BRISTOL-MYERS SQUIBB COMPANY, Lawrenceville-Princeton Road, Princeton, New Jersey 08543-4000 , US | Applicant ref. no. | 134079 | Inventor | COHEN, Robert, 120 Meadowview Drive
Newton, PA 18940, US, CARR, Suzette, 579 Province Line Road
Hopewell, NJ 08525, US, HAGERTY, David, 3 Nobadeer Drive
Pennington, NJ 08534, US, BECKER, Jean-Claude, 16 Halstead Place
Princeton, NJ 08543, US, PEACH, Robert, J., 12848 Via Caballo Rojo
San Diego, CA 92129, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 38/17 (2006.01) , A61K 45/06 (2006.01) , A61P 19/02 (2006.01) , A61P 37/04 (2006.01) | Title | Fremgangsmåder til behandling af rheumatiske sygdomme under anvendelse af et opløseligt CTLA4-molekyle | Int. application no. | US2001021204 | Int. publication no. | WO2002002638 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|